SciSparc (NASDAQ:SPRC) Stock Price Up 9.4% – Here’s Why

SciSparc Ltd. (NASDAQ:SPRC) was up 9.4% on Thursday . The stock traded as high as $5.40 and last traded at $5.36. 42,523 shares changed hands during mid-day trading, a decline of 1% from the average daily volume of 43,100 shares. The stock had previously closed at $4.90.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of SciSparc in a research report on Tuesday, May 26th. Wall Street Zen upgraded SciSparc to a “hold” rating in a research report on Saturday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, SciSparc presently has an average rating of “Sell”.

SciSparc Trading Down 6.7%

The business has a fifty day moving average price of $6.51 and a 200 day moving average price of $6.55.

SciSparc (NASDAQ:SPRC) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($31.60) earnings per share for the quarter. The company had revenue of $0.20 million during the quarter.

About SciSparc

SciSparc AG is a clinical‐stage medical technology company focused on the development and commercialization of extracorporeal shock wave–based neuromodulation devices. Founded in 2016 and headquartered in Switzerland, the company applies proprietary low‐intensity shock wave technology to noninvasively stimulate neural tissue. SciSparc completed its initial public offering on the NASDAQ in 2021 under the ticker SPRC, securing funding to advance its clinical pipeline.

The company’s lead product, the TR100 system, delivers transcranial shock wave stimulation (tSWS) designed to target areas of the brain associated with motor control and cognitive function.